台灣肺炎治療準則 2000 Taiwan Pneumonia Antimicrobial Treatment Guideline 2000 中華民國感染症醫學會 台灣胸腔及重症加護醫學會.

Slides:



Advertisements
Similar presentations
Chest Infections Lawrence Pike.
Advertisements

TREATMENT FOR SUPERIMPOSED PSEUDOMONAS AERUGINOSA INFECTION.
Monotherapy Versus Combination Therapy
Antibiotics.
Choosing Antimicrobials in Special Situations. Additional considerations in making a final antibiotic selection Site of action – (Will the antibiotic.
Community-acquired bacterial infections. The most frequent etiologic agents of bacterial tonsillitis and tonsillopharyngitis are Streptococcus pyogenes.
Pneumonia Why do we need to know about it? Long recognized as a major cause of death, Pneumonia has been studied intensively since late 1800s. Despite.
MINOR CRITERIAA RESPIRATORY RATEB _30 BREATHS/MIN PAO2/FIO2 RATIOB _250 MULTILOBAR INFILTRATES CONFUSION/DISORIENTATION UREMIA (BUN LEVEL, _20 MG/DL) LEUKOPENIAC.
Community- acquired Pneumonia Author Dr. Shek Kam Chuen Oct 2013 HKCEM College Tutorial.
Acute infections of the lower airways in children Aleksandra Szczawińska-Popłonyk Department of Pediatric Pneumonology, Allergology and Clinical Immunology.
Guidelines for antimicrobial therapy of urinary tract infections in Taiwan Infectious Diseases Society of the Republic of China, Medical foundation in.
Bugs and Drugs: an approach to the management of infections J. Pernica Division of Pediatric Infectious Diseases.
James Clayton Consultant Microbiologist
Gram-positive bacteria: Staphylococci
Gram Positive Pathogens
ANTIBIOTICS.
Empiric Treatment: Pneumonia. Overview of Pneumonia diseases.asp?did=38http://
Resistance to  -lactam antibiotics within the Enterobacteriaceae Paul D. Fey, Ph. D. University of Nebraska Medical Center.
ANTIMICROBIAL AGENTS AND PRINCIPLES OF THERAPY Prof T Rogers Clinical Microbiology TCD.
Gram Negative Gram Positive
A Survey From Major Guidelines ..in the treatment of CAP & bronchitis
Culture and Sensitivity Helping the Infection Preventionist Interpret Antibiograms Walter Phillips, BS, MS, PhD Director of Microbiology TriStar Healthcare.
Antibiotics 101 Puja Van Epps 1/20/14.
Hospital Acquired Pneumonia
Methods Revised Abstract Methods Results TP-271 is a Potent, Broad-Spectrum Fluorocycline with Activity Against Community-Acquired Bacterial Respiratory.
General Rules On Use of Antimicrobial Agents Consultant Microbiologist & Head of the Bacteriology By: Prof. A.M.Kambal.
Beta lactam antibiotics & Other cell wall synthesis inhibitors
Antibiotic Pearls in the Emergency Department
Antibiogram panel Designing
ANTIBIOTICS (Foundation Block, Microbiology).
DHS/PP Antimicrobial Therapy David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle.
Clinical Cases Beta-Lactam Answers. Case 1 What antibiotic would you recommend for intravenous therapy in a 40yo BM with a Staphylococcus aureus (MSSA)
Lecturer name: Dr. Fawzia Alotaibi Lecturer name: Dr. Fawzia Alotaibi & Dr. Ali Somily Department of Pathology, Microbiology Unit Lecture Title: ANTIBIOTICS.
Gram Positive Pathogens Staphylococcus Streptococcus Enterococcus Listeria monocytogenes Bacillus anthracis.
INF 1 ® Life-Threatening Infections INF 1 ®. INF 2 ® Objectives Recognize predisposing conditions for infection Identify clinical manifestations of infection.
Respiratory Tract infections. PROF. AzzA ELMedany Department of pharmacology.
Nebraska Public Health Laboratory 2008 CLSI M100-S18 update Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training.
Antibiotics Foundation Block
Listing Antimicrobial Resistant Pathogens of Public Health Importance Implications for Drug Development Listing Antimicrobial Resistant Pathogens of Public.
Figure 1 shows the 10 most frequently isolated blood pathogens in these hospitals from 1997 through These species represent about 85% of blood isolates.
Antibiotics 101 A review of common infections and their treatment For others, like me, who have a mental block against all things related to antibiotics.
Impetigo The best topical agent is mupirocin; other agents, such as bacitracin and neomycin, are less effective. Patients who have numerous lesions or.
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
 Community-acquired pneumonia (CAP) is a disease in which individuals who have not recently been hospitalized develop an infection of the lungs (pneumonia).
Diagnosis, Empiric Management and Prevention of CAP
ANTIMICROBIAL AGINST B- LACTAMASE PRODUCERS 1)ANTISTAPH PENECILLINS e.g.CLOXACILLIN. 2)CEPHALOSPORINS. 3)CLINDAMYCIN. 4)CIPROFLOXACIN AND OTHER QUINOLONES.
Supplemental testing methods
Impetigo Mupirocin; (bacitracin and neomycin, are less effective.) numerous lesions or not responding to topical agents: oral antimicrobials effective.
Antimicrobial Agents & Mechanisms of Resistance BY Prof. DR. Zainalabideen A. Abdulla, DTM&H., MRCPI, Ph.D., FRCPath. (U.K.)
Treatment Of Respiratory Tract infections. Prof. Azza ELMedany Department of Pharmacology Ext
N.meningitidis Ceftriaxone- children and adults Cefotaxime- neonates Ampicillin Chloramphenicol N. gonorrhea Ceftriaxone Cefotaxime Ciprofloxacin Spectinomycin.
Treatment of Respiratory Tract infections. Prof. Azza EL-Medany.
Pneumonia in infancy and childhood
Lecture 23-Antibiotic Therapy-2-Lecture Objectives
Principles of Medical Science Pharmacology Review
Internal Medicine Mini-Lecture. Learning Points  Basics  Choosing antibiotics  Overview.
Pneumonia: not just a Gram-negative issue ?
The Role of the Microbiology Laboratory in AMS programs
Antimicrobial Spectrum of Activity Visual Learning Exercises (“Flower Diagrams”) This work is licensed under the Creative Commons Attribution-NonCommercial-
Antimicrobial Agents Antibiotics:
Interior Health Pharmacy Resident Kootenay Lake Hospital
Intro to Antibiotics By: Alaina Darby.
By :Lecturer Nabeel Ahmed Al anbagi
به نام خدا.
PHARMACOTHERAPY III PHCY 510
b-Lactamase Inhibitors
In the Name of GOD.
Antibiotics: What are they & How they are used
Presentation transcript:

台灣肺炎治療準則 2000 Taiwan Pneumonia Antimicrobial Treatment Guideline 2000 中華民國感染症醫學會 台灣胸腔及重症加護醫學會

Community -Acquired Pneumonia Age group Primary Alternative <2m Ampicillin+ Aminoglycosides Ampicillin+ cefotaxime (or ceftriaxone) ± Erythromycin 2m-2y Ampicillin/sulbactam Ceftriaxone (or cefotaxime) Amoxicillin/clavulanate Ceftazidime  2º cephalosporins Aminoglycoside 2y-5y Ampicillin/sulbactam Ceftriaxone (or cefotaxime) Amoxicillin/clavulanate 2º cephalosporins ± Erythromycin or new macrolides 5y- 18y Penicillin  Erythromycin Ampicillin/sulbactam or new macrolides Amoxicillin/clavulanate 2º and 3ºcephalosporins

Community -Acquired Pneumonia Age group Primary Alternative y Penicillin  Erythromycin Ampicillin/sulbactam or new macrolides Amoxicillin/clavulanate 2º cephalosporins Tetracycline Fluoroquinolones >60y Mild-moderate Penicillin or 2º cephalosporins Ampicillin/sulbactam  Erythromycin Tetracycline or new macrolides Amoxicillin/clavulanate Newer fluoroquinolones Severe 3º cephalosporins or Fluoroquinolones or Ureidopenicillins  Ticarcillin/clavulanate or Aminoglycosides  Piperacillin/tazobactam or Erythromycin or 4º cephalosporins  new macrolides Aminoglycosides  Erythromycin or new macrolides

Aspiration Pneumonia (Including Lung abscess) Pathogens Primary Alternative Anaerobes Penicillin Penicillin + metronidazole S. pneumoniae Clindamycin 2  Cephalosporins Other Streptococci Ampicillin/sulbactam Enterobacteriaceae Amoxicillin/clavulanate

Hospital -Acquired Pneumonia Pathogens Primary Alternative Mild to moderate Ampicillin/sulbactam or Ticarcillin/clavulanate or Amoxicillin/clavulanate or Piperacillin/tazobactam or 2º or 3º cephalosporins or Aztreonam or Ureidopenicillins  Fluoroquinolones  Aminoglycosides Aminoglycosides Severe 3º cephalosporins or Ticarcillin/clavulanate or Ureidopenicillins or Piperacillin/tazobactam or Fluoroquinolones + Aztreonam or Aminoglycosides  Imipenem or meropenem or Erythromycin or 4º cephalosporins + newer macrolides  Aminoglycosides  Vancomycin or teicoplanin Erythromycin or newer macrolides  Vancomycin or teicoplanin

Ventilator Associated Pneumonia Pathogens Primary Alternative P. aeruginosa 3º cephalosporins or Ticarcillin/clavulanate or Acinetobacter Ureidopenicillins or Piperacillin/tazobactam or MRSA Fluoroquinolones + Aztreonam or Aminoglycosides  Imipenem or meropenem or Vancomycin or teicoplanin 4º cephalosporins + Aminoglycosides  Vancomycin or teicoplanin

Community -Acquired Pneumonia Pathogens Primary Alternative Streptococcus pneumoniae Penicillin MIC  1  g/mL Penicillin 1° Cephalosporins Ampicillin or amoxicillin 2  g/mL Penicillin (12-18MU/d) 3ºor 4° cephalosporins Ampicillin or amoxicillin  4  g/mL 3ºor 4° cephalosporins Vancomycin or teicoplanin Vancomycin or teicoplanin + Rifampicin Newer fluoroquinolone

Community -Acquired Pneumonia Pathogens Primary Alternative Haemophilus influenza  -lactamase (-) Ampicillin or amoxicillin New macrolides TMP/SMX  -lactamase (+) Ampiclllin/sulbactam 3ºcephalosporins Amoxicillin/clavulanate New macrolides 2° cephalosporins Fluoroquinolones Moraxella catarrhalis Ampiclllin/sulbactam Erythromycin Amoxicillin/clavulanate or new macrolides 2° cephalosporins 3ºcephalosporins FluoroquinoloneS

Community -Acquired Pneumonia Pathogens Primary Alternative Legionella species Erythromycin or Erythromycin or new macrolides new macrolides + Rifampicin Tetracycline Fluoroquinolones Mycoplasma pneumonia Erythromycin or Tetracycline new macrolides Fluoroquinolones Chlamydia pneumoniae Tetracycline Fluoroquinolones Erythromycin or new macrolides